IL157588A0 - Carbamate compounds for use in preventing or treating psychotic disorders - Google Patents

Carbamate compounds for use in preventing or treating psychotic disorders

Info

Publication number: IL157588A0
Authority: IL; Israel
Prior art keywords: preventing; psychotic disorders; carbamate compounds; treating psychotic; treating
Prior art date: 2001-02-27

Application number

IL15758802A

Original Assignee

Ortho Mcneil Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-27

Filing date

2002-02-21

Publication date

2004-03-28

2002-02-21 Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc

2004-03-28 Publication of IL157588A0 publication Critical patent/IL157588A0/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IL15758802A 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders IL157588A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US27188901P	2001-02-27	2001-02-27
PCT/US2002/006119 WO2002067927A1 (en)	2001-02-27	2002-02-21	Carbamate compounds for use in preventing or treating psychotic disorders
US10/081,761 US6541513B2 (en)	2001-02-27	2002-02-21	Carbamate compounds for use in preventing or treating psychotic disorders

Publications (1)

Publication Number	Publication Date
IL157588A0 true IL157588A0 (en)	2004-03-28

Family

ID=26765939

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL15758802A IL157588A0 (en)	2001-02-27	2002-02-21	Carbamate compounds for use in preventing or treating psychotic disorders
IL157588A IL157588A (en)	2001-02-27	2003-08-26	Carbamate compounds for use in preventing or treating psychotic disorders

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL157588A IL157588A (en)	2001-02-27	2003-08-26	Carbamate compounds for use in preventing or treating psychotic disorders

Country Status (25)

Country	Link
US (1)	US6541513B2 (en)
EP (1)	EP1401424B1 (en)
JP (1)	JP4276841B2 (en)
KR (1)	KR100886578B1 (en)
CN (1)	CN1262271C (en)
AR (1)	AR032876A1 (en)
AT (1)	ATE346597T1 (en)
AU (1)	AU2002242296B2 (en)
BR (1)	BR0207829A (en)
CA (1)	CA2439480C (en)
CZ (1)	CZ302412B6 (en)
DE (1)	DE60216457T2 (en)
DK (1)	DK1401424T3 (en)
ES (1)	ES2275844T3 (en)
HU (1)	HUP0303342A3 (en)
IL (2)	IL157588A0 (en)
MX (1)	MXPA03007722A (en)
NO (1)	NO20033801L (en)
NZ (1)	NZ527991A (en)
PL (1)	PL365021A1 (en)
PT (1)	PT1401424E (en)
RS (1)	RS51056B (en)
RU (1)	RU2302240C2 (en)
TW (1)	TWI251486B (en)
WO (1)	WO2002067927A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL365701A1 (en) *	2000-07-21	2005-01-10	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
DE60220043T2 (en) *	2001-02-27	2008-01-10	Ortho-Mcneil Pharmaceutical, Inc.	CARBAMATE COMPOUNDS FOR PREVENTING OR TREATING NEURODEEGENERATIVE DISORDER
DE60210960T2 (en)	2001-02-27	2006-11-16	Ortho-Mcneil Pharmaceutical, Inc.	CARBAMATE COMPOUNDS FOR THE PREVENTION OR TREATMENT OF DIFFICULTIES
RU2303445C2 (en)	2001-07-16	2007-07-27	Орто-Макнейл Фармасьютикал, Инк.	Carbamate compounds for using in prophylaxis or treatment of neuropathic pain and pain associated with claster and migraine headache
WO2005107719A2 (en) *	2004-05-06	2005-11-17	Sandoz Ag	Pharmaceutical composition comprising hydrophobic drug having improved solubility
CN101272776B (en) *	2005-07-26	2012-10-03	詹森药业有限公司	Use of carbamate in the preparation of medicines for treating substance abuse-related diseases
EA200970436A1 (en) *	2006-10-30	2009-12-30	Янссен Фармацевтика, Н.В.	CARBAMATE CONNECTIONS FOR THE TREATMENT OF DEPRESSION
AU2007313911A1 (en) *	2006-10-31	2008-05-08	Janssen Pharmaceutica, N.V.	Treatment of Pervasive Developmental Disorders
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
KR20160004260A (en)	2013-03-12	2016-01-12	(주)바이오팜솔루션즈	Phenyl carbamate compound and a composition for neuroprotection comprising the same
CN105228604A (en)	2013-03-12	2016-01-06	比皮艾思药物研发有限公司	Phenylcarbamate compounds for preventing or treating epilepsy and epilepsy-related syndromes in children
KR102900173B1 (en) *	2016-12-14	2025-12-12	에스케이바이오팜 주식회사	Use of carbamate compound for prevention, alleviation or treatment of psychiatric disorder selected from schizophrenia, obsessive-compulsive disorder and tourette syndrome

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US278380A (en) *		1883-05-29		Thermometer
US3313692A (en) *	1958-04-21	1967-04-11	Armour Pharma	Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) *	1962-07-18	1966-08-09	Armour Pharma	Substituted phenethyl carbamates
AU626427B2 (en) *	1989-06-09	1992-07-30	Pharmacia & Upjohn Company	Heterocyclic amines having central nervous system activity
US5492930A (en)	1994-04-25	1996-02-20	Schering Corporation	Method and formulation for treating CNS disorders
US5698588A (en) *	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

2002
- 2002-02-21 DK DK02707927T patent/DK1401424T3/en active
- 2002-02-21 JP JP2002567294A patent/JP4276841B2/en not_active Expired - Lifetime
- 2002-02-21 HU HU0303342A patent/HUP0303342A3/en unknown
- 2002-02-21 CN CNB028089235A patent/CN1262271C/en not_active Expired - Fee Related
- 2002-02-21 AT AT02707927T patent/ATE346597T1/en active
- 2002-02-21 EP EP02707927A patent/EP1401424B1/en not_active Expired - Lifetime
- 2002-02-21 AU AU2002242296A patent/AU2002242296B2/en not_active Ceased
- 2002-02-21 ES ES02707927T patent/ES2275844T3/en not_active Expired - Lifetime
- 2002-02-21 US US10/081,761 patent/US6541513B2/en not_active Expired - Lifetime
- 2002-02-21 IL IL15758802A patent/IL157588A0/en unknown
- 2002-02-21 CA CA2439480A patent/CA2439480C/en not_active Expired - Fee Related
- 2002-02-21 BR BR0207829-5A patent/BR0207829A/en not_active Application Discontinuation
- 2002-02-21 RU RU2003128983/14A patent/RU2302240C2/en active
- 2002-02-21 DE DE60216457T patent/DE60216457T2/en not_active Expired - Lifetime
- 2002-02-21 PT PT02707927T patent/PT1401424E/en unknown
- 2002-02-21 WO PCT/US2002/006119 patent/WO2002067927A1/en not_active Ceased
- 2002-02-21 CZ CZ20032297A patent/CZ302412B6/en not_active IP Right Cessation
- 2002-02-21 KR KR1020037011292A patent/KR100886578B1/en not_active Expired - Lifetime
- 2002-02-21 NZ NZ527991A patent/NZ527991A/en unknown
- 2002-02-21 RS YUP-675/03A patent/RS51056B/en unknown
- 2002-02-21 MX MXPA03007722A patent/MXPA03007722A/en active IP Right Grant
- 2002-02-21 PL PL02365021A patent/PL365021A1/en unknown
- 2002-02-27 AR ARP020100702A patent/AR032876A1/en unknown
- 2002-03-05 TW TW091103972A patent/TWI251486B/en not_active IP Right Cessation
2003
- 2003-08-26 IL IL157588A patent/IL157588A/en not_active IP Right Cessation
- 2003-08-26 NO NO20033801A patent/NO20033801L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE60216457D1 (en)	2007-01-11
US6541513B2 (en)	2003-04-01
HUP0303342A2 (en)	2004-01-28
KR100886578B1 (en)	2009-03-05
MXPA03007722A (en)	2004-11-12
ES2275844T3 (en)	2007-06-16
WO2002067927A1 (en)	2002-09-06
IL157588A (en)	2009-12-24
US20020165272A1 (en)	2002-11-07
DK1401424T3 (en)	2007-02-26
RS51056B (en)	2010-10-31
EP1401424A1 (en)	2004-03-31
TWI251486B (en)	2006-03-21
RU2003128983A (en)	2005-03-10
RU2302240C2 (en)	2007-07-10
BR0207829A (en)	2004-06-22
DE60216457T2 (en)	2007-09-20
CN1262271C (en)	2006-07-05
JP2004523556A (en)	2004-08-05
RS67503A (en)	2006-12-15
KR20030076713A (en)	2003-09-26
NZ527991A (en)	2005-04-29
HUP0303342A3 (en)	2012-07-30
CZ20032297A3 (en)	2004-06-16
PL365021A1 (en)	2004-12-27
EP1401424B1 (en)	2006-11-29
PT1401424E (en)	2007-02-28
NO20033801L (en)	2003-10-22
NO20033801D0 (en)	2003-08-26
ATE346597T1 (en)	2006-12-15
AR032876A1 (en)	2003-11-26
CZ302412B6 (en)	2011-05-04
CA2439480A1 (en)	2002-09-06
CA2439480C (en)	2011-04-26
CN1505507A (en)	2004-06-16
AU2002242296B2 (en)	2006-06-29
JP4276841B2 (en)	2009-06-10

Publication	Publication Date	Title
IL173439A0 (en)	2006-06-11	[1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
PT2311466E (en)	2015-10-27	Antimicrobial compounds and methods for their use
HUP0501116A3 (en)	2010-01-28	Oxynthomodulin for preventing or treating excess weight
GB0112343D0 (en)	2001-07-11	Well treatment
IL160208A0 (en)	2004-07-25	Amidine derivatives for treating amyloidosis
IL157592A0 (en)	2004-03-28	Carbamate compounds for use in preventing or treating movement disorders
IL157591A0 (en)	2004-03-28	Carbamate compounds for use in preventing or treating neurodegenerative disorders
PL368556A1 (en)	2005-04-04	Methods for treating or preventing skin disorders using cd2-binding agents
GB0113841D0 (en)	2001-08-01	Therapeutic agents
HUP0303261A3 (en)	2012-07-30	Carbamate compounds for use in preventing or treating bipolar disorder
IL157588A0 (en)	2004-03-28	Carbamate compounds for use in preventing or treating psychotic disorders
HUP0303236A3 (en)	2012-07-30	Carbamate compounds for use in the treatment of pain
HUP0303243A3 (en)	2012-07-30	Carbamate compounds for use in preventing and treating bipolar disorder
GB0108930D0 (en)	2001-05-30	Therapeutic agents
GB0113839D0 (en)	2001-08-01	Therapeutic agents
EP1419236A4 (en)	2005-08-03	Methods for treating or preventing sclerotic disorders using cd2-binding agents
GB0113842D0 (en)	2001-08-01	Therapeutic agents
GB0111191D0 (en)	2001-06-27	Therapeutic agents
AU2002342188A8 (en)	2003-06-23	Methods and compositions for treating flavivirus-mediated disease
GB0108982D0 (en)	2001-05-30	Therapeutic agents
ZA200307477B (en)	2005-01-03	Carbamate compounds for use in preventing or treating movement disorders.
PL354980A1 (en)	2004-03-22	Use dexrazoxane for treating psoriasis
HUP0402141A3 (en)	2007-02-28	Herbicidal composition and process for its use
ZA200307473B (en)	2005-01-03	Carbamate compounds for use in preventing or treating neurodegenerative disorders.
TWI318876B (en)	2010-01-01	Carbamate compounds for use in preventing or treating bipolar disorder